Page last updated: 2024-10-23

bisindolylmaleimide v and Diabetic Angiopathies

bisindolylmaleimide v has been researched along with Diabetic Angiopathies in 1 studies

bisindolylmaleimide V: used as a negative control compound for protein kinase C inhibition; structure in first source;

Diabetic Angiopathies: VASCULAR DISEASES that are associated with DIABETES MELLITUS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Booth, G1
Stalker, TJ1
Lefer, AM1
Scalia, R1

Other Studies

1 other study available for bisindolylmaleimide v and Diabetic Angiopathies

ArticleYear
Mechanisms of amelioration of glucose-induced endothelial dysfunction following inhibition of protein kinase C in vivo.
    Diabetes, 2002, Volume: 51, Issue:5

    Topics: Animals; Aorta; Cell Adhesion; Diabetic Angiopathies; Endothelium, Vascular; Enzyme Inhibitors; Gluc

2002